• 图文组件
  • 图文组件
  • 图文组件


  1. He J, Chen J, Miao M, Zhang R, Cheng G, Wang Y, Feng R, Huang B, Luan H, Jia Y, Jin Y, Zhang X, Shao M, Wang Y, Zhang X, Li J, Zhao X, Wang H, Liu T, Xiao X, Zhang X, Su Y, Mu R, Ye H, Li R, Liu X, Liu Y, Li C, Liu H, Hu F, Guo J, Liu W, Zhang WB, Jacob A, Ambrus JL Jr, Ding C, Yu D, Sun X, Li Z. Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(11):e2241451. (IF:13.353)
  2. Zhang X, Miao M, Zhang R, Liu X, Zhao X, Shao M, Liu T, Jin Y, Chen J, Liu H, Zhang X, Li Y, Zhou Y, Yang Y, Li R, Yao H, Liu Y, Li C, Li Y, Ren L, Su Y, Sun X, He J, Li Z. Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduct Target Ther. 2022 Mar 7;7(1):67.(IF:38.104)
  3. Xiaolin Sun, Haotian Zhou, Xiaozhen Zhao, Ruijun Zhang, Miao Miao, Wenwen Pei, Zijun Li, Yimin Li, Jing He, and Zhanguo Li. Low-dose IL-2 supplementation mitigates glucocorticoid induced Treg impairment and promotes improvement of SLE. Signal Transduct Target Ther.(已接收, IF:38.104)
  4. Guo J, Zhang T, Li X, Cao H, Li Z. Response to: 'Questions on 'Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population' by Guo et al' by Regueiro and Gonzalez. Ann Rheum Dis. 2022 Mar;81(3):e39. (IF:27.973)
  5. Li J, Jin J, Li S, Zhong Y, Jin Y, Zhang X, Xia B, Zhu Y, Guo R, Sun X, Guo J, Hu F, Xiao W, Huang F, Ye H, Li R, Zhou Y, Xiang X, Yao H, Yan Q, Su L, Wu L, Luo T, Liu Y, Guo X, Qin J, Qi H, He J, Wang J, Li Z. Tonsillar Microbiome-Derived Lantibiotics Induce Structural Changes of IL-6 and IL-21 Receptors and Modulate Host Immunity. Adv Sci. 2022 Oct;9(30):e2202706. (IF:17.521)
  6. He J, Chu Y, Li J, Meng Q, Liu Y, Jin J, Wang Y, Wang J, Huang B, Shi L, Shi X, Tian J, Zhufeng Y, Feng R, Xiao W, Gan Y, Guo J, Shao C, Su Y, Hu F, Sun X, Yu J, Kang Y, Li Z. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis. Sci Adv. 2022 Feb 11;8(6):eabm1511. (IF:14.957)
  7. Li Z, He J, Miao M. Low-dose interleukin-2 therapy in autoimmune and inflammatory diseases: facts and hopes. Sci Bull. (IF:11.78,已接收)
  8. Xing Y, Li B, He J, Hua H. Labial Gland Mesenchymal Stem Cell Derived Exosomes-Mediated miRNA-125b Attenuates Experimental Sjogren's Syndrome by Targeting PRDM1 and Suppressing Plasma Cells. Front Immunol. 2022 Apr 4;13:871096. (IF:8.786)
  9. Jin J, Xu X, Hou L, Hou Y, Li J, Liang M, Li C. Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome. Front Immunol. 2022 Aug 18;13:971005. (IF:8.786)
  10. Song X, Fan Y, Jia Y, Li G, Liu M, Xu Y, Zhang J, Li C. A novel aGAPSS-based nomogram for the prediction of ischemic stroke in patients with antiphospholipid syndrome. Front Immunol. 2022 Jul 29;13:930087. (IF:8.786)
  11. Liu X, Zhu L, Liu H, Cai Q, Yun Z, Sun F, Jia Y, Guo J, Li C. Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added. Front Immunol. 2022 Oct 26;13:972012. (IF:8.786)
  12. Yuzhou Gan, Xue Zhong, Yawei Zhao, Gongming Li, Hua Ye and Chun Li. Low Dose Versus Standard Dose Rituximab For The Treatment of Antiphospholipid Syndrome: A Pilot Study From a Tertiary Medical Center. Front Immunol, 2022. (IF:8.786)
  13. Han P, Hou C, Zheng X, Cao L, Shi X, Zhang X, Ye H, Pan H, Liu L, Li T, Hu F, Li Z. Serum Antigenome Profiling Reveals Diagnostic Models for Rheumatoid Arthritis. Front Immunol. 2022;13:884462. (IF:8.786)
  14. Liu X, Zhu L, Liu H, Cai Q, Yun Z, Sun F, Jia Y, Guo J, Li C. Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added. Front Immunol. 2022 Oct 26;13:972012. (IF:8.786)
  15. Zhou X, Wang Y, Huang B, Feng R, Zhou X, Li C, Zhang X, Shao M, Gan Y, Jin Y, An Y, Xiao X, Wang S, Liu Q, Cheng G, Zhu F, Zhang K, Wang N, Xing X, Li R, Li Y, Liu Y, Lu D, Sun X, Li Z, Liu Y, He J. Dynamics of T follicular helper cells in patients with rheumatic diseases and subsequent antibody responses in a three-dose immunization regimen of CoronaVac. Immunology. 2022 Sep 3.( IF:7.215)
  16. Liu H, Li C, Shi H, Guo Y, Tang Y, Chen C, Zhao Z, Hoy CK, Yalavarthi S, Figueroa-Parra G, Duarte-Garcia A, Zuo Y, Li Z, Knight JS, Guo J. Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APS. Rheumatology (Oxford). 2022 Mar 24:keac192.( IF:7.046)
  17. Zhang K, An Y, Zhao P, Huang B, Wang Y, Zhou X, Cheng G, Xing X, Wang N, Feng R, Yu S, Li M, He J, Li Z. Predictors and prognostic stratification for lupus low disease activity state: Results from a prospective clinical trial. Rheumatology (Oxford). 2022 Jul 27:keac419. ( IF:7.046)
  18. Zhong H, Liu T, Liu Y, Zhang X, Zhou Y, Su Y. Efficacy and safety of tocilizumab in Behçet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China. Rheumatology (Oxford). 2022 Jul 6;61(7):2923-2930. ( IF:7.046)
  19. Xie Y, Jia Y, Li Z, Hu F. Scavenger receptor A in immunity and autoimmune diseases: Compelling evidence for targeted therapy. Expert Opin Ther Targets. 2022 May;26(5):461-477.( IF:6.797)
  20. Guo Q, He Y, Liu X, Gao X, Xu J, Li X, Sun Y, Xiang Y, Li R, Li Z. Features of hyperintense white matter lesions and clinical relevance in systemic lupus erythematosus. Chin Med J. 2022 Apr 20;135(8):962-970. (IF:6.133)
  21. Li C, Zuo Y, Zhang S, Makris UE, Karp DR, Li Z. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients. Chin Med J 2022 Mar 20;135(6):658-664. (IF:6.133)
  22. Gao X, He J, Sun X, Li F. Dynamically modeling the effective range of IL-2 dosage in the treatment of systemic lupus erythematosus. iScience. 2022 Aug 11;25(9):104911. (IF:6.106)
  23. Zhufeng Y, Xu J, Miao M, Wang Y, Li Y, Huang B, Guo Y, Tian J, Sun X, Li J, Lu D, Li Z, Li Y, He J. Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study. Front Cell Infect Microbiol. 2022 Mar 14;12:757099. (IF:6.073)
  24. Wu M, Yu S, Chen Y, Meng W, Chen H, He J, Shen J, Lin X. Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity. J Leukoc Biol. 2022 Oct;112(4):875-885. (IF:6.011)
  25. Shi M, Gao W, Jin Y, Zhu J, Liu Y, Wang T, Li C. Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition. Front Cardiovasc Med. 2022 Jul 11;9:872523. (IF:5.846)
  26. Gan Y, Zhao Y, Li G, Ye H, Zhou Y, Hou C, Wang L, Guo J, Li C. Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome. Front Cardiovasc Med. 2022 Jul 5;9:871011. (IF:5.846)
  27. Xie Y, Jiang X, Wang P, Zheng X, Song J, Bai M, Tang Y, Fang X, Jia Y, Li Z, Hu F. SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis. Clin Exp Immunol. 2022 May 12;207(3):297-306. (IF:5.732)
  28. Zheng L, Xu L, Hu F, Xue J, Bai M, Yao R, Zhu H, Zhong H, Su Y. Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis. Clin Exp Immunol. 2022 Sep 29;209(3):270-279. (IF:5.732)
  29. Feng R, Zhao J, Sun F, Miao M, Sun X, He J, Li Z. Comparison of the deep immune profiling of B cell subsets between healthy adults and Sjögren's syndrome. Ann Med. 2022 Dec;54(1):472-483. (IF:5.348)
  30. Wang Y, Feng R, Cheng G, Huang B, Tian J, Gan Y, Jin Y, Miao M, Zhang X, Sun X, He J, Li Z. Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model. Front Med (Lausanne). 2022 May 19;9:887354.(IF:5.058)
  31. Shi Q, Ning X, Li H, Ma X, Wang K, Bian W, Zhang Y, Xia J, Zheng X, Liu Y, Li Z. Characteristics of IgG4-related disease complicated with allergic rhinitis or chronic rhinosinusitis: a large cross-sectional cohort study. Sci Rep. 2022 Jul 14;12(1):12039. (IF:4.996)
  32. Cai W, Li R, He J, Shao M, Li Z. A Rare Case of Neurosarcoidosis Overlapped with Sjogren's Syndrome. J Clin Med. 2022 Sep 27;11(19):5709. (IF:4.964)
  33. Li Y, Li Y, Wang Y, Shi L, Lin F, Zhang Z, Zhang J, Xu F, Sun X. Nomogram to predict dermatomyositis prognosis: a population-based study of 457 cases. Clin Exp Rheumatol. 2022 Feb;40(2):247-253. (IF:4.862)
  34. Zhang Y, Bao H, Zhang X, Yang F, Liu Y, Li H, Lu J, Liu Y. Kimura's disease: clinical characteristics, management and outcome of 20 cases from China. Clin Exp Rheumatol. 2022 Mar;40(3):532-538. (IF:4.862)
  35. Miao M, Li Y, Xu D, Zhang R, He J, Sun X, Li Z. Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus. Clin Exp Rheumatol. 2022 May;40(5):867-871. (IF:4.862)
  36. Wang Z, Li J, Zhang X, Zeng Q, Wang Z, Yang F, Bian W, Fu J, Zhang Y, Chi X, Wu Y, Shi Q, An Z, Liu Y. Clinical characteristics of IgG4-related respiratory disease patients: a large Chinese cohort study. Clin Exp Rheumatol. 2022 Sep;40(9):1629-1635. (IF:4.862)
  37. Bai M, Xu L, Zhao Z, Xue J, Zhong H, Liu T, Sun F, Yao H, Hu F, Su Y. Decreased perforin-producing B cells correlate with systemic lupus erythematosus. Clin Exp Rheumatol. 2022 Aug 31. (IF:4.862)
  38. Guo Y, Li X, Li R, Li Y, Wang Z, Liu H, Cao S, Li R, Zhao Y, Wang Q, Sun X. Utility of autoantibody against an UCH-L1 epitope as a serum diagnostic marker for neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol. 2022 Nov;40(11):2078-2087. (IF:4.862)
  39. Shao M, Miao M, Zhang X, Zhang X, An Y, Guo H, Lei L, Zhao Q, Ding Y, Lin J, Wu R, Yu F, Li Y, Miao H, Zhang L, Du Y, Jiao R, Pang L, Long L, Yao X, Shi X, Wang F, Cui L, Zhang L, Liu S, Lu F, Luo K, Zhao S, Wang Y, Wu X, Wang Q, Liu H, Song S, Zhou X, Zhang X, Shi S, Zhu H, Chen Y, Yu H, Wu J, Yu R, Fan W, Liu S, Xu J, Chen Z, Shi L, He J, Zhang X, Li Z, Li R. Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study. Lupus Sci Med. 2022 Nov;9(1):e000779. (IF:4.687)
  40. Liu Y, Liu S, Liu L, Gong X, Liu J, Sun L, Liu X, Wu L, Chen L, Wang L, Luo L, Lin J, Tie N, Jiang Z, Wu J, Lu F, Sun H, Li X, Yang N, Chai K, Wei H, Da Z, Zhao C, Dai L, Wang Y, Shi G, Zhang Z, Song H, Guo Q, Liu YC, Li Z. Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study. Rheumatol Ther. 2022 Feb;9(1):175-189.( IF:4.081)
  41. Bian W, Li Y, Sun F, Sun X, Li R, Xia C, Fu J, Zhang Y, Chen S, Liu Y. Immune phenotype changes in IgG4-related disease: CD161 + Treg and Foxp3 +  Clin Rheumatol. 2022 Dec 25. (IF:3.65)
  42. Gao C, Zhong H, Chen L, Wang L, Yao H, Huang X, Jia Y, Li C, Liu T. Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study. Clin Rheumatol. 2022 Apr;41(4):1235-1240. (IF:3.65)
  43. Zhou X, Li Q, Li Y, Fu J, Sun F, Li Y, Wang Y, Jia Y, Zhang Y, Jia R, Hu F, Li Y. Diminished natural killer T-like cells correlates with aggravated primary Sjögren's syndrome. Clin Rheumatol. 2022 Apr;41(4):1163-1168. (IF:3.65)
  44. Luo L, Li X, Yan R, Zhang H, Li C. Risk factors for adverse pregnancy outcomes in women with rheumatoid arthritis and follow-up of their offspring. Clin Rheumatol. 2022 Oct;41(10):3135-3141. (IF:3.65)
  45. Cao L, Zheng X, Han P, Ren L, Wang J, Hu F, Li Z. Raman spectroscopy as a promising diagnostic method for Rheumatoid Arthritis. Analytical Methods. (IF:3.6,已接收)
  46. Liu Y, Wang Z, Ren L, Zeng Q, Wang Z, Bian W, Zhang Y, Fu J, Chen D, Yu G, Zhang S, Li Z. Sonographic findings of immunoglobulin G4-related sialadenitis and differences from Sjögren's syndrome. Scand J Rheumatol. 2022 Mar;51(2):128-134. (IF:3.057)
  47. Wei Y, Zhao J, Ming J, Zhang X, Chen Y. Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China. Patient Prefer Adherence. 2022 Aug 31;16:2387-2398. (IF:2.314)
  48. Zhou W, Liu T, Xiao X, He J. Refractory Behçet's disease treated with low-dose interleukin-2: A case report. Medicine (Baltimore). 2022 Oct 21;101(42):e31173. (IF:1.817)
  49. Yan R, Jin YB, Li XR, Luo L, Liu XM, He J. Clinical characteristics of rheumatic disease-associated hypophysitis: A case series and review of literature. Medicine. 2022 Oct 28;101(43):e31338. (IF:1.552)
  50. Alexander Jacob, Long Shen, Jing He, Kelly Nealon, Jessy J, Alexander Julian L, Ambrus Jr. Effect of lymphotoxin blockage on different stages of Sjogren's syndrome in an animal model. Rheumatol & Autoimmun. 2022;2:76–81.
  51. Zhao X, Chen Y, Wen W, et al. Identification of lipopolysaccharide-binding protein as a novel citrullinated autoantigen in rheumatoid arthritis. Rheumatol & Autoimmun. 2022;2:5-14.
  52. Xing XY, Zhang JX, Zhu FY, Wang YF, Zhou XY, Li YH. Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome. Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1214-1218. Chinese.
  53. Li GM, Jin YB, Gan YZ, Chen C, Jia Y, Li C. Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review. Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1208-1213. Chinese.
  54. Cai WX, Li SC, Liu YM, Liang RY, Li J, Guo JP, Hu FL, Sun XL, Li C, Liu X, Ye H, Deng LZ, Li R, Li ZG. A cross-sectional study on the clinical phenotypes of rheumatoid arthritis. Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Dec 18;54(6):1068-1073.
  55. Mu R, Li C, Li X, Ke Y, Zhao L, Chen L, Wu R, Wu Z, Zuo X, Xie Y, Chen J, Wei W, Liu Y, Li Z, Dai L, Sun L, Liu X, Li Z. Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study. Lancet Reg Health West Pac. 2021 Mar 22;10:100128.
  56. Sun X, Li R, Cai Y, Al-Herz A, Lahiri M, Choudhury MR, Hidayat R, Suryana BPP, Kaneko Y, Fujio K, Van Hung N, Pandya S, Pang LK, Katchamart W, Sigdel KR, Paudyal B, Narongroeknawin P, Chevaisrakul P, Sun F, Lu Y, Ho C, Yeap SS, Li Z; APLAR RA SIG group. Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region. Lancet Reg Health West Pac. 2021 Aug 12;15:100240.
  57. Deng J, Chen Q, Chen Z, Liang K, Gao X, Wang X, Makota FV, Ong HS, Wan Y, Luo K, Gong D, Yu X, Camuglia S, Zeng Q, Zhou T, Xue F, He J, Wei Y, Xiao F, Ma J, Hill DL, Pierson W, Nguyen THO, Zhou H, Wang Y, Shen W, Sun L, Li Z, Xia Q, Qian K, Ye L, Rockman S, Linterman MA, Kedzierska K, Shen N, Lu L, Yu D. The metabolic hormone leptin promotes the function of TFH cells and supports vaccine responses. Nat Commun. 2021 May 24;12(1):3073.
  58. Zhang Y, Li Y, Zhang J, Chen X, Zhang R, Sun G, Jiang B, Fan K, Li Z, Yan X. Nanocage-Based Capture-Detection System for the Clinical Diagnosis of Autoimmune Disease. Small. 2021 Jun;17(25):e2101655.
  59. Zeng Q, Gao J, Zhang X, Liu A, Wang Z, Wang Z, Chi X, Shi Q, Wang Y, Yang F, Liu Y, Li ZG. Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case-control study based on 450 patients. Sci Rep. 2021 May 17;11(1):10397.
  60. Jin J, Li J, Gan Y, Liu J, Zhao X, Chen J, Zhang R, Zhong Y, Chen X, Wu L, Xiang X, Zhou Y, He J, Guo J, Liu X, Li Z. Red meat intake is associated with early onset of rheumatoid arthritis: a cross-sectional study. Sci Rep. 2021 Mar 11;11(1):5681.
  61. Liu H, Zou Y, Chen C, Tang Y, Guo J. Current Understanding of Circular RNAs in Systemic Lupus Erythematosus. Front Immunol. 2021 Feb 25;12:628872.
  62. Chen J, Sun F, Bao H, Liang L, Zhan M, Yao H, He J, Liu Y. Elevated Serum Human Epididymis Protein 4 Is Associated With Disease Activity and Systemic Involvements in Primary Sjögren's Syndrome. Front Immunol. 2021 Jun 23;12:670642.
  63. Liang Y, Xian Z, Fu D, Liu S, Yao Y, Jin Y, Gao C, Shen L, Shi G, He J. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome. Front Immunol. 2021 May 3;12:673658.
  64. Liang K, He J, Wei Y, Zeng Q, Gong D, Qin J, Ding H, Chen Z, Zhou P, Niu P, Chen Q, Ding C, Lu L, Chen XX, Li Z, Shen N, Yu D, Deng J. Sustained low-dose interleukin-2 therapy alleviates pathogenic humoral immunity via elevating the Tfr/Tfh ratio in lupus. Clin Transl Immunology. 2021 Jun 1;10(6):e1293. 
  65. Liu Y, Zhu L, Wang Z, Zeng Q, Yang F, Gao J, Wang Z, Wang K, Ren L, Zhang Y, Zhang S, Wang Y, Shen D, Xia C, Yu G, Li Z. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study. Rheumatology (Oxford). 2021 Feb 1;60(2):767-772.
  66. Zhou X, Liu Y, Jin Y, Wang Y, Miao M, Chen J, Cheng Y, Liu Y, He J, Li Z. Immune responses after influenza vaccination in patients of primary Sjögren's syndrome. Rheumatology (Oxford). 2021 Jan 5;60(1):224-230.
  67. Chen S, Guo C, Wang R, Feng Z, Liu Z, Wu L, Zhao D, Zheng S, Chen F, Zhang D, Xu J, Zhu J, Chen X, Li Z, Wise CM, Li J, Wang XY. Monocytic MDSCs skew Th17 cells toward a pro-osteoclastogenic phenotype and potentiate bone erosion in rheumatoid arthritis. Rheumatology (Oxford). 2021 May 14;60(5):2409-2420.
  68. Wang Y, Xiao J, Duan Y, Miao M, Huang B, Chen J, Cheng G, Zhou X, Jin Y, He J, Li Z, So KF. Lycium barbarum Polysaccharide Ameliorates Sjögren's Syndrome in a Murine Model. Mol Nutr Food Res. 2021 Jun;65(11):e2001118.
  69. Miao M, Xiao X, Tian J, Zhufeng Y, Feng R, Zhang R, Chen J, Zhang X, Huang B, Jin Y, Sun X, He J, Li Z. Therapeutic potential of targeting Tfr/Tfh cell balance by low-dose-IL-2 in active SLE: a post hoc analysis from a double-blind RCT study. Arthritis Res Ther. 2021 Jun 11;23(1):167.
  70. Zhao Z, Mou D, Wang Z, Zeng Q, Wang Z, Xue J, Ren L, Liu Y, Su Y. Clinical features and relapse risks of IgG4-related ophthalmic disease: a single-center experience in China. Arthritis Res Ther. 2021 Mar 31;23(1):98.
  71. Liu Y, Yang F, Chi X, Zhang Y, Fu J, Bian W, Shen D, Li Z. Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease. Arthritis Res Ther. 2021 Feb 10;23(1):54.
  72. Li X, Ye H. bFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patients. Arthritis Res Ther. 2021 Oct 15;23(1):261.
  73. Fu W, Liu Y, Liu F, Liu C, Li J, Niu J, Han P, Xu D, Hou J, Ma Y, Feng J, Li Z, Mu R, Yang G. A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus Nephritis. Front Immunol. 2021 Mar 25;12:656090.
  74. Yang Y, Xu J, Xu J, Li X, Hu J, Li X, Zhang X, He D, Bao C, Li Z, Wang G, Zerbini CAF, Spindler AJ, Kannowski CL, Wu H, Ji F, Zhan L, Liu M, Li Z. Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study. Ther Adv Musculoskelet Dis. 2021 Apr 20;13:1759720X211006964.
  75. Hu F, Tang Y, Wang P, Bai M, Li X, Song J, Shi L, Sun X, Jin M, Li Z, Li X. Endoplasmic reticulum stress perpetuated toll-like receptor signalling-mediated inflammation in rheumatoid arthritis via X-box-binding protein-1. Clin Exp Rheumatol. 2021 Jul-Aug;39(4):859-867.
  76. Miao M, Li Y, Xu D, Zhang R, He J, Sun X, Li Z. Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus. Clin Exp Rheumatol. 2021 May 5.
  77. Bonfá E, Gossec L, Isenberg DA, Li Z, Raychaudhuri S. How covid-19 is changing rheumatology clinical practice. Nat Rev Rheumatol. 2020 Nov 2:1-5.
  78. Huizinga TW, Holers VM, Anolik J, Brenner MB, Buckley CD, Bykerk V, Connolly SE, Deane KD, Guo J, Hodge M, Hoffmann S, Nestle F, Pitzalis C, Raychaudhuri S, Yamamoto K, Li Z, Klareskog L. Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress. Ann Rheum Dis. 2020; 79: 553-555.
  79. Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79:685-699.
  80. Xue J, Xu L, Zhu H, et al. CD14+CD16- monocytes are the main precursors of osteoclasts in rheumatoid arthritis via expressing Tyro3TK. Arthritis Res Ther. 2020; 22:221.
  81. Yang Y, Li XF, Zhang X, et al. Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE. Rheumatol Ther. 2020. doi: 10.1007/s40744-020-00231-6.
  82. Gao C, Chen L, Liu T. Clinical and Psychological Assessment of Rheumatoid Arthritis Patients with Fibromyalgia: A Real World Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10)
  83. Chen JL,Liu T,Liu YD, et al. Correspondence on‘Critical role of neutrophil extracellular traps (NETs) in patients with Behcet's disease by Joncour et al'. Annals of Rheumatic Disease, accept.
  84. Li R, Sun X, Ye H, et al. Validation of new classification criteria of rheumatoid arthritis in an international multicentre study. Clin Exp Rheumatol. 2020; 38: 841-847.
  85. Y Zou, Y Fei, H Gao, et al. Association between musculoskeletal ultrasonography and bone remodelling markers and its role in disease monitoring of gout and hyperuricaemia. Clin Exp Rheumatol. 2020; 38: 896-902.
  86. Hu F, Jiang X, Guo C, et al. Scavenger receptor-A Is a Biomarker and Effector of Rheumatoid Arthritis: A Large-Scale Multicenter Study. Nature Communications. 2020; 11:1911.
  87. Shi L, Hu F, Zhu L, et al. CD70-mediated CD27 expression downregulation contributed to the regulatory B10 cell impairment in rheumatoid arthritis. Molecular Immunology. 2020;119:92-100.
  88. Hu F, Tang Y, Wang P, et al. Endoplasmic reticulum stress perpetuated toll-like receptor signalling-mediated inflammation in rheumatoid arthritis via X-box-binding protein-1. Clin Exp Rheumatol. 2020 Sep 8. Online ahead of print.
  89. Li X, Xiang X, Sun J, et al. Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study. Mod Rheumatol. 2020;30:321-326.
  90. Li M, Cheng G, Wang Z, et al. Anti-recoverin antibodies indicate fundus abnormalities in systemic lupus erythematosus. Lupus. 2020; 29:1346-1352.
  91. Li Y, Gao X, Li Y, et al. Predictors and mortality of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathy:a series of 474 patients. Front Med (Lausanne). 2020; 7:363.
  92. Hu S, Liu X, Li T, et al. LAG3 (CD223) and autoimmunity: Emerging evidence. J Autoimmun. 2020;112:102504.
  93. Liu Y, Zeng Q, Zhu L, et al. Relapse Predictors and Serologically Unstable Condition of IgG4-related Disease: A Large Chinese Cohort. Rheumatology (Oxford). 2020; 59: 2115-2123.
  94. Cai YM, Li R, Ye H, et al. Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study. Chin Med J (Engl). 2020;133:1397-1403.
  95. Xu J, Zhang XY, Li R, et al. Glucose-6-phosphate isomerase is associated with disease activity and declines in response to infliximab treatment in rheumatoid arthritis. Chin Med J (Engl). 2020;133:886-891.
  96. You X, Zhang R, Shao M, et al. Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission. Front Med (Lausanne). 2020;7:85.
  97. Jin J, Li J, Gan Y, et al. Tea Consumption Is Associated with Decreased Disease Activity of Rheumatoid Arthritis in a Real-World, Large-Scale Study. Ann Nutr Metab. 2020;76:54-61.
  98. Li Y, Jia R, Liu Y, et al. Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity. Lupus. 2020;29:239-247.
  99. Liu YY, Wang SY, Li YN. Activity of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis was impaired by Dickkopf-1 targeting siRNA. Chin Med J (Engl). 2020;133:679-686.
  100. Gan YZ, Zhang LH, Ma L, et al. Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis. Chin Med J (Engl). 2020 ;133:644-649.
  101. Liu Y, Zhang Y, Bian W, et al. Efficacy and safety of iguratimod on patients with relapsed or refractory IgG4-related disease. Clin Rheumatol. 2020;39:491-497.
  102. Liu Y, Xue M, Wang Z, Zeng Q, Ren L, Zhang Y, Zhang S, Wang Y, Shen D, Xia C, Yu G, Li ZG. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Rheumatology (Oxford). 2020 Mar 1;59(3):634-640.
  103. He J, Zhang R, Shao M, Zhao X, Miao M, Chen J, Liu J, Zhang X, Zhang X, Jin Y, Wang Y, Zhang S, Zhu L, Jacob A, Jia R, You X, Li X, Li C, Zhou Y, Yang Y, Ye H, Liu Y, Su Y, Shen N, Alexander J, Guo J, Ambrus J, Lin X, Yu D, Sun X, Li Z. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2020 Jan;79(1):141-149.
  104. An Y, Zhou Y, Bi L, Liu B, Wang H, Lin J, Xu D, Wang M, Zhang J, Wang Y, An Y, Zhu P, Xie R, Zhang Z, Mei Y, Liu X, Deng X, Yao Z, Zhang Z, Wang Y, Xiao W, Shen H, Yang X, Xu H, Yu F, Wang G, Lu X, Li Y, Li Y, Zuo X, Li Y, Liu Y, Zhao Y, Guo J, Sun L, Zhao M, Li Z. Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study. Clin Rheumatol. 2019 Apr;38(4):1047-1054.
  105. Guo J, Zhang T, Cao H, Li X, Liang H, Liu M, et al. Sequencing of the MHC region defines HLA-DQA1 as the major genetic risk for seropositive rheumatoid arthritis in Han Chinese population. Ann Rheum Dis. 2019;78(6):773-80.
  106. Jin Y, Li J, Chen J, Shao M, Zhang R, Liang Y, et al. Tissue-Specific Autoantibodies Improve Diagnosis of Primary Sjogren's Syndrome in the Early Stage and Indicate Localized Salivary Injury. J Immunol Res. 2019;2019:3642937.
  107. Li R, Sun X, Liu X, Yang Y, Li Z. Autoimmune diseases in China. Adv Immunol. 2019;144:173-216.
  108. Li X, Sun J, Mu R, Gan Y, Wang G, He J, Yi L, Wang Q, Sun X, Li Z. The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol. 2019 May-Jun;37(3):474-480.
  109. Li X, Xiang X, Sun J, Liu S, Liu Y, Feng L, Li C, Li Z. Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study. Mod Rheumatol. 2020 Mar;30(2):321-326.
  110. Li Y, Ren L, Liu X, Zhao X, Hu F, Li Z. Pulse corticosteroids in treatment of rheumatic disease concomitant with cytomegalovirus infection. Int J Rheum Dis. 2019;22(4):583-91.
  111. Liu JJ, Li R, Gan YZ, Zhang RJ, Li J, Cai YM, Zhao JX, Liao H, Xu J, Shi LJ, Li J, Li SG, Sun XL, He J, Liu X, Ye H, Li ZG. Clinical deep remission and related factors in a large cohort of patients with rheumatoid arthritis. Chin Med J (Engl). 2019 May 5;132(9):1009-1014.
  112. Liu Y, Xue M, Wang Z, Zeng Q, Ren L, Zhang Y, et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients. Rheumatology (Oxford). 2019.
  113. Shao M, He J, Zhang R, Zhang X, Yang Y, Li C, et al. Interleukin-2 Deficiency Associated with Renal Impairment in Systemic Lupus Erythematosus. J Interferon Cytokine Res. 2019;39(2):117-24.
  114. Wang H, Wang Y, Tang Y, Ye H, Zhang X, Zhou G, Lv J, Cai Y, Li Z, Guo J, Wang Q. Frequencies of the LILRA3 6.7-kb Deletion Are Highly Differentiated Among Han Chinese Subpopulations and Involved in Ankylosing Spondylitis Predisposition. Front Genet. 2019 Sep 18;10:869.
  115. Xu L, Song X, Su L, Zheng Y, Li R, Sun J. New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases. Int Immunopharmacol. 2019;72:322-9.
  116. Zhao D, Chen Z, Hu S, Lin J, Shao Z, Wang G, et al. Efficacy and Safety of Loxoprofen Hydrogel Transdermal Patch Versus Loxoprofen Tablet in Chinese Patients with Myalgia: A Double-Blind, Double-Dummy, Parallel-Group, Randomized, Controlled, Non-Inferiority Trial. Clin Drug Investig. 2019;39(4):369-77.
  117. Wang J, Wang C, Liang Y, Pan H, Jiang Z, Li Z, Li Y, Xia L, Liu W, Zhang X, Liu Z, Jiang M, Liu J, Zhou H, Liu L. Serum IgG N-glycans act as novel serum biomarkers of ankylosing spondylitis. Ann Rheum Dis. 2019 May;78(5):705-707.
  118. Li X, Sun J, Mu R, Gan Y, Wang G, He J, Yi L, Wang Q, Sun X, Li Z. The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol. 2019 May-Jun;37(3):474-480.
  119. Bi L, Li Y, He L, Xu H, Jiang Z, Wang Y, Li X, Wei W, Gu J, Wang G, Zhang Z, Zhou B, Liu Y, Wu Z, Liu H, He D, Lv Z, Li Z, Zuo X, Dong L, Wu H, Zhang H, Chen H, Bao C, Zhang Z, Zhang M, Song H, Zheng Y, Jiang L, Liu X, Boehnlein M, Dunkel J, Shao J, Harris K, Li Z. Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study. Clin Exp Rheumatol. 2019 Mar-Apr;37(2):227-234.
  120. Zhou Y, Wang X, An Y, Zhang X, Han S, Li X, Wang L, Wang C, Wang Y, Yang R, Wang G, Lu X, Zhu P, Chen L, Liu J, Jin H, Liu X, Sun L, Wei P, Wang J, Chen H, Cui L, Shu R, Zhang Z, Li G, Li Z, Yang J, Li J, Jia B, Zhang F, Tao J, Lin J, Wei Q, Liu X, Ke D, Hu S, Ye C, Yang X, Li H, Huang C, Gao M, Li X, Song L, Wang Y, Wang X, Mu R, Su Y, Li Z. Disability and health-related quality of life in Chinese patients with rheumatoid arthritis: A cross-sectional study. Int J Rheum Dis. 2018 Sep;21(9):1709-1715. doi: 10.1111/1756-185X.13345.
  121. Zhu H, Li R, Da Z, Bi L, Li X, Li Y, Liu C, Zhang F, Li Z, Liu X, Zhang Z, Sun L, Wang Y, Zhang W, Jiang Q, Chen J, Chen Q, Li Z, Wu L, Qi W, Xu J, Cui X, Wang X, Li L, Leng X, Wang G, Zhao D, Jiang L, He D, Liu X, Li L, Fang Y, Huang C, Wu H, Hu S, Li Q, Song H, Xiao W, Gong L, Zhang L, Li X, Li Z, Su Y. Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study. Clin Rheumatol. 2018 Mar;37(3):597-605.
  122. Chen X, Sun X, Yang W, Yang B, Zhao X, Chen S, He L, Chen H, Yang C, Xiao L, Chang Z, Guo J, He J, Zhang F, Zheng F, Hu Z, Yang Z, Lou J, Zheng W, Qi H, Xu C, Zhang H, Shan H, Zhou XJ, Wang Q, Shi Y, Lai L, Li Z, Liu W. An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. Science. 2018 Nov 9;362(6415):700-705.
  123. Xiao W, Guo JP, Li C, Ye H, Wei W, Zou Y, Dai L, Li Z, Zhang M, Li X, Cai X, Zhao J, Wang Y, Tao Y, Liu D, Li Y, Wu M, Sun E, Wu L, Luo L, Mu R, Li Z. Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis. Pharmacogenomics. 2018 Apr;19(5):383-392.
  124. Su L, Yang Y, Jia Y, Liu X, Zhang W, Yuan Y, Li Z. Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia: A case report. Medicine (Baltimore). 2018 Jul;97(28):e11501.
  125. Yang Y, Chen L, Jia Y, Liu Y, Wen L, Liang Y, An Y, Chen S, Su Y, Li Z. Monoclonal gammopathy in rheumatic diseases. Clin Rheumatol. 2018 Jul;37(7):1751-1762.
  126. Li Z, An Y, Su H, Li X, Xu J, Zheng Y, Li G, Kwok K, Wang L, Wu Q. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial. Int J Rheum Dis. 2018 Feb;21(2):402-414.
  127. Mu R, Liang J, Sun L, Zhang Z, Liu X, Huang C, Zhu P, Zuo X, Gu J, Li X, Li X, Liu Y, Feng P, Li Z. A randomized multicenter clinical trial of 99 Tc-methylene diphosphonate in treatment of rheumatoid arthritis. Int J Rheum Dis. 2018 Jan;21(1):161-169.
  128. Wen L, Zhu C, Zhu Z, Yang C, Zheng X, Liu L, Zuo X, Sheng Y, Tang H, Liang B, Zhou Y, Li P, Zhu J, Ding Y, Chen G, Gao J, Tang L, Cheng Y, Sun J, Elango T, Kafle A, Yu R, Xue K, Zhang Y, Li F, Li Z, Guo J, Zhang X, Zhou C, Tang Y, Shen N, Wang M, Yu X, Liu S, Fan X, Gao M, Xiao F, Wang P, Wang Z, Zhang A, Zhou F, Sun L, Yang S, Xu J, Yin X, Cui Y, Zhang X. Exome-wide association study identifies four novel loci for systemic lupus erythematosus in Han Chinese population. Ann Rheum Dis. 2018 Mar;77(3):417.
  129. Wen W, Li Y, Cheng Y, He J, Jia R, Li C, Guo J, Sun X, Li Z. Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis. Clin Exp Rheumatol. 2018 Mar-Apr;36(2):233-240.
  130. He J, Li Z. An era of biological treatment in systemic lupus erythematosus. Clin Rheumatol. 2018 Jan;37(1):1-3.
  131. Wang J, Lin F, Wan Z, Sun X, Lu Y, Huang J, Wang F, Zeng Y, Chen YH, Shi Y, Zheng W, Li Z, Xiong C, Liu W. Profiling the origin, dynamics, and function of traction force in B cell activation. Sci Signal. 2018 Aug 7;11(542).
  132. Guo J, Gao Y, Wang Y, Zou Y, Du Y, Luo C, Shi Y, Yang Y, Wu X, Su Y, Wu L, Chen S, Li Z. Investigation of C1-complex regions reveals new C1Q variants associated with protection from systemic lupus erythematosus, and affect its transcript abundance. Sci Rep. 2018 May 23;8(1):8048.
  133. Hu F, Zhang W, Shi L, Liu X, Jia Y, Xu L, Zhu H, Li Y, Xu D, Lu L, Qiu X, Liu W, Qiao J, Wang Y, Li Z. Impaired CD27+IgD+ B Cells With Altered Gene Signature in Rheumatoid Arthritis. Front Immunol. 2018 Mar 23;9:626.
  134. Gao H, Zou YD, Zhang XW, He J, Zhang J, Sun Y, Li ZG. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study. Int J Rheum Dis. 2018 Jul;21(7):1423-1429. doi: 10.1111/1756-185X.13334.
  135. Gao H, Zhang XW, He J, Zhang J, An Y, Sun Y, Jia RL, Li SG, Zhang LJ, Li ZG. Medicine (Baltimore). 2018 Jun;97(24):e11003. Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sjögren syndrome patients: A case-control study.
  136. Gao H, Ma XX, Guo Q, Xie LF, Zhong YC, Zhang XW. Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis. Clin Rheumatol. 2018 Aug;37(8):2073-2080.
  137. Meng Y, Zhang M, Zhao X, Cheng Y, Jia R, Wang Y, Sun X. Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus. Clin Rheumatol. 2018 Oct;37(10):2707-2714.
  138. Li X, Qian YQ, Liu N, Mu R, Zuo Y, Wang GC, Jia Y, Li ZG. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study. Clin Rheumatol. 2018 Nov;37(11):3051-3056.
  139. Zhao X, Cheng Y, Gan Y, Jia R, Zhu L, Sun X. Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations. Clin Rheumatol. 2018 May;37(5):1229-1237.
  140. Shao M, Sun XL, Sun H, He J, Zhang RJ, Zhang X, Li ZG. Clinical Relevance of Autoantibodies against Interleukin-2 in Patients with Systemic Lupus Erythematosus. Chin Med J (Engl). 2018 Jul 5;131(13):1520-1526.
  141. Zhang RJ, Zhang X, Chen J, Shao M, Yang Y, Balaubramaniam B, Sun XL, Ambrus JL Jr, He J, Li ZG. Serum soluble CD25 as a risk factor of renal impairment in systemic lupus erythematosus - a prospective cohort study. Lupus. 2018 Jun;27(7):1100-1106.
  142. Zhou G, Sun X, Qin Q, Lv J, Cai Y, Wang M, Mu R, Lan HY, Wang QW. Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis. Front Immunol. 2018 Nov 2;9:2537.
  143. Li C, Wang XR, Ji HJ, Zhang XY, Li XF, Wang LZ, Wang CH, Wang YF, Yang R, Wang GC, Lu X, Zhu P, Chen LN, Jin HT, Liu JT, Liu XY, Sun L, Chen HY, Wei P, Wang JX, Cui LF, Shu R, Liu BL, Zhang ZL, Li GT, Li ZB, Yang J, Li JF, Jia B, Zhang FX, Tao JM, Han SL, Lin JY, Wei MQ, Liu XM, Ke D, Hu SX, Ye C, Yang XY, Li H, Huang CB, Gao M, Lai B, Li XF, Song LJ, Wang Y, Wang XY, Tang YD, Su Y, Mu R, Li ZG. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China. Clin Rheumatol. 2017 May;36(5):1023-1029.
  144. Li S, Guo Q, Zhu H, Li Z, Su Y, Dong B.Increased Mer and Axl receptor tyrosine kinase expression on glomeruli in lupus nephritis. Clin Rheumatol. 2017 May;36(5):1063-1070.
  145. Xu L, Liu X, Liu H, Zhu L, Zhu H, Zhang J, Ren L, Wang P, Hu F, Su Y. Impairment of Granzyme B-Producing Regulatory B Cells Correlates with Exacerbated Rheumatoid Arthritis. Front Immunol. 2017 Jun 30;8:768.
  146. Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, Su Y, Li ZG. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. Clin Rheumatol. 2017 Feb;36(2):401-406.
  147. Gan Y, Zhao X, He J, Liu X, Li Y, Sun X, Li Z. Increased interleukin-17F is associated with elevated autoantibody level and more clinically relevant than interleukin-17A in primary Sjögren's Syndrome. J Immunol Res. 2017;47
  148. Hu F, Liu H, Liu X, Zhang X, Xu L, Zhu H, Li Y, Shi L, Ren L, Zhang J, Li Z, Jia Y.Pathogenic conversion of regulatory B10 cells into osteoclast-priming cells in rheumatoid arthritis. J Autoimmun. 2017 Jan;76:53-62.
  149. Xu L, Hu F, Zhu H, Liu X, Shi L, Li Y, Zhong H, Su Y. Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: Correlation with disease activity and bone destruction. Clin Exp Immunol. 2017 Nov 17. doi: 10.1111/cei.13082.
  150. He J, Li Z. The rise of IL-2 therapy - a picture beyond Treg cells. Nature Reviews Rheumatology. 2017 Jun;13(6):386.
  151. Chen Y, Hu F, Dong X, Zhao M, Wang J, Sun X, Kim TJ, Li Z, Liu W. SHIP-1 Deficiency in AID+ B Cells Leads to the Impaired Function of B10 Cells with Spontaneous Autoimmunity. J Immunol. 2017 Nov 1; 199(9):3063-3073.
  152. Liu AC, Yang Y, Li MT, Jia Y, Chen S, Ye S, Zeng XZ, Wang Z, Zhao JX, Liu XY, Zhu J, Zhao Y, Zeng XF, Li ZG. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China. Clin Rheumatol. 2017 Apr 13.
  153. Cui L, Meng L, Wang G, Yuan X, Li Z, Mu R*, Wu S*. Prevalence and risk factors of hyperuricemia: results of the Kailuan cohort study. Mod Rheum. 2017. Apr. 11:1-6. doi: 10.1080/14397595.2017.1300117.
  154. Li C, Liu N, Zhu H, Xu L, Mu R*. Elevated serum interleukin-35 is associated with disease activity in patients with systemic lupus erythematosus. Int J Rheum Dis. 2017 Jul 27. doi: 10.1111/1756-185X.13128.
  155. Mu R, Liang J, Sun L, et al. A randomized multicenter clinical trial of 99Tc-methylene diphosphonate in treatment of rheumatoid arthritis. Int J Rheum Dis. 2017;20(10)
  156. Cui LF, Shi HJ, Wu SL, Shu R, Liu N, Wang GY, Zhou B, Sun K, Yu P, Wang J, Song HC, Yang WH, Wang JR, Han YX, Mu R*. Association of serum uric acid and risk of hypertension in adults: a prospective study of Kailuan Corporation cohort. Clin Rheumatol. 2017;36(5):1103-1110. doi:10.1007/s10067-017-3548-2.
  157. Chen J,Chen S,He J.A case of refractory intestinal Behçet's disease treated with tocilizumab, a humanised anti-interleukin-6 receptor antibody. Clin Exp Rheumatol.2017 Nov;35 Suppl 108(6):116-118.
  158. Brandon W. Higgs, Yanying Liu, Jianping Guo et al. High-throughput RNA sequencing reveals distinct gene signatures in active IgG4-related disease. Scientific Reports, 2017, 7:17567.
  159. Yuan Li, Yunshan Zhou, Qian Wang. Multiple values of 18F-FDG PET/CT in idiopathic inflammatory myopathy. Clin Rheumatol. 2017;36:2297-2305.
  160. Wang JR, Gao WN, Grimm R, Jiang S, Liang Y, Ye H, Li ZG, Yau LF, Huang H, Liu J, Jiang M, Meng Q, Tong TT, Huang HH, Lee S, Liu 1, Jiang ZH. A method to identify trace sulfated IgG N-glycans as biomarkers for rheumatoid arthritis. Nat Commun. 2017 Sep 20;8(1):631. doi: 10.1038/s41467-017-00662-w.
  161. Yuan An, Tian Liu, Dongyi He, Lijun Wu, Juan Li, Yi Liu, Liqi Bi, Bing Zhou, Changsong Lin, Lan He, Xiangyuan Liu, Xiaofeng Li, Niansheng Yang, Zhuoli Zhang, Hui Song, Wei Wei,Jing Liu, Zhanguo Li.The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study. Clin Rheumatol.2017,Jan(36);35-43
  162. Meng Xia, Juan Liu, Shuxun Liu, Kun Chen, Hongyu Lin, Minghong Jiang, Xiaoqing Xu, Yiquan Xue, Wei Liu, Yan Gu, Xiang Zhang, Zhiqing Li, Lin Yi, Youcun Qian, Chen Zhou, Ru Li, Xuan Zhang, Zhanguo Li, Xuetao Cao. Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity. Nat Commun. 2017; 8: 15818
  163. Qi YY, Zhou XJ, Nath SK, Sun C, Wang YN, Hou P, Mu R, Li C, Guo JP, Li ZG, Wang G, Xu HJ, Hao YJ, Zhang ZL, Yue WH, Zhang HR, Zhao MH, Zhang H. A rare variant (rs933717) at FBXO31-MAP1LC3B in Chinese is associated with systemic lupus erythematosus. Arthritis Rheumatol. 2017 Oct 17. doi: 10.1002/art.40353.
  164. Xia Hong, Yan-Yan Zhang, Wei Li, Yan-Ying Liu, Zhen Wang, Yan Chen, Yan Gao, Zhi-Peng Sun, Xin Peng, Jia-Zeng Su, Zhi-Gang Cai, Lei Zhang, Jing He, Li-Min Ren, Hong-Yu Yang, Zhan-Guo Li, Guang-Yan Yu.Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents. Arthritis Res Ther. 2017 Dec. accept.
  165. Yu-Hui Li,Ya-Ping Gao, Jie Dong, Lian-Jie Shi, Xiao-Lin Sun, Ru Li, Xue-Wu Zhang, Yu Liu, Li Long, Jing-He, Qun-Jie Zhong, Eric Morand, Guang Yang, and Zhan-Guo Li. Identification of a novel autoantibody against self-vimentin specific in secondary Sjögren’s syndrome. Arthritis Res Ther. 2017 Dec. accept.
  166. Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG; International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland). 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017 Dec;76(12):1955-1964.
  167. He J, Zhang X, Wei Y, Sun X, Chen Y, Deng J, Jin Y, Gan Y, Hu X, Jia R, Xu C, Hou Z, Leong YA, Zhu L, Feng J, An Y, Jia Y, Li C, Liu X, Ye H, Ren L, Li R, Yao H, Li Y, Chen S, Zhang X, Su Y, Guo J, Shen N, Morand EF, Yu D, Li Z. Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus Nature Medicine. 2016 Sep;22(9):991-3.
  168. Xu L, Xia M, Guo J, Sun X, Li H, Xu C, Gu X, Zhang H, Yi J, Fang Y, Xie H, Wang J, Shen Z, Xue B, Sun Y, Meckel T, Chen YH, Hu Z, Li Z, Xu C, Gong H, Liu W. Impairment on the lateral mobility induced by structural changes underlies the functional deficiency of the lupusassociated polymorphism FcγRIIB-T232s JEM. 2016 Nov 14;213(12):2707-2727.
  169. Liu Y, Mu R, Gao YP, Dong J, Zhu L, Ma Y, Li YH, Zhang HQ, Han D, Zhang Y, McInnes IB, Zhang J, Shen B, Yang G, Li ZG. A Cytomegalovirus Peptide-Specific Antibody Alters Natural Killer Cell Homeostasis and Is Shared in Several Autoimmune DiseasesCell Host & Microbe. 2016 Mar 9;19(3):400-8
  170. Guo C, Hu F, Yi H, Feng Z, Li C, Shi L, Li Y, Liu H, Yu X, Wang H, Li J, Li Z, Wang XY. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis Ann Rheum Dis. 2016 Jan;75(1):278-85.
  171. Li L, Wen W, Jia R, Li Y, Liu X, Sun X, Li Z. GITRL is associated with increased autoantibody production in patients with rheumatoid arthritis. Clin Rheumatol. 2016 Sep;35(9):2195-202.
  172. Zhu W, Sun X, Zhu L, Gan Y, Baiwu R, Wei J, Li Z, Li R, Sun J. A Novel BLyS Peptibody Down-Regulates B Cell and T Helper Cell Subsets In Vivo and Ameliorates Collagen-Induced Arthritis Inflammation. 2016 Apr;39(2):839-48.
  173. Li R, Zhao JX, Su Y, He J, Chen LN, Gu F, Zhao C, Deng XR, Zhou W, Hao YJ, Xue Y, Liu HX, Zhao Y, Zou QH, Liu XY, Zhu P, Sun LY, Zhang ZL, Zou HJ, Li XF, Liu Y, Fang YF, Keystone E, McInnes IB, Li ZG. High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial Medicine (Baltimore). 2016; Jul;95(28)
  174. Hu F, Liu H, Xu L, Li Y, Liu X, Shi L, Su Y, Qiu X, Zhang X, Yang Y, Zhang J, Li Z. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis Eur. J. Immunol. 2016; 46(3):742-51
  175. Li R, Liu X, Ye H, Yao HH, Guo JL, Li GT, Li XF, Xue Y, Zhao JX, Gu F, Zou QH, Chen LN, Bi LQ, Zhang ZL, Zou HJ, Liu XY, Sun LY, Fang YF, Zhu P, Su Y, Li ZG. Magnetic resonance imaging in early rheumatoid arthritis: a multicenter, prospective study. Clin Rheumatol. 2016; 35:303–308
  176. Ye H, Su Y, Li R, Zhao J, Liu X, Mei Y, Zhang Z, Guo J, Bi L, Liu X, Wang G, Liu J, Leng X, Gu F, Sun L, Zou Q, Fang Y, Jiang Q, Li Z.Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort Clin Rheumatol. 2016; Oct;35(10):2397-401
  177. Guo J, Li Z. Genetic markers and clinical relevance in rheumatoid arthritis International Journal of Rheumatic Diseases. 2016; 19: 109–113
  178. Ren LM, Li R, Chen LN, Zhu P, Gu F, Sun LY, Zhao JX, Liu XY, Guo JL, Bi LQ, Hao YJ, Zhang ZL, Mei YF, Zhang ZY, Liu HX, Li XF, Luo Y, Fang YF, Li ZG, Su Y. Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: A randomized, multi-center study. International journal of rheumatic diseases. 2016 Jul;19(7):651-7
  179. Shao W, Hu F, Ma J, Zhang C, Liao Q, Zhu Z, Liu E, Qiu X.Epithelial cells are a source of natural IgM that contribute to innate immune responses Int J Biochem Cell Biol. 2016; 73:19-29
  180. Zhang SL, Liu N, Wei XQ, Lu Q, Mu R, Li ZG. Decreased interleukin-35 levels are associated with higher risk of pregnancy morbidity in patients with antiphospholipid syndrome Clin Exp Rheumatol. 2016; 34(3):562-3
  181. Guo Q, Zha X, Li C, Jia Y, Zhu L, Guo J, Su Y. Serum calprotectin–a promising diagnostic marker for adult-onset Still's disease Clin Rheumatol. (2016) 35:73–79
  182. He J, Wang Y, Feng M, Zhang X, Jin YB, Li X, Su LC, Liu S, Wang AX, Chen XM, Wu LJ, Yu XX, Xu N, Liu XY, Yan HM, Wang YF, Jia B, Li JF, Tao JM, Zhang FX, Yu P, Cui LF, Yang J, Li ZB, Xie JL, Wei P, Sun WW, Gong L, Cheng YJ, Huang CB, Wang XY, Wang Y, Guo HF, Jin HT, Liu X, Wang GC, Wang YH, He L, Zhao Y, Li XX, Zhang Y, Guo JP, Li ZG. Dietary intake and risk of rheumatoid arthritis-a cross section multicenter study. Clin Rheumatol. 2016 Dec;35(12):2901-2908